Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (Date of earliest event reported): May 7,
2010
MEDASORB
TECHNOLOGIES CORPORATION
(Exact
name of registrant as specified in its charter)
Nevada
|
|
000-51038
|
|
98-0373793
|
(State
or other jurisdiction of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer Identification
Number)
|
7
Deer Park Drive, Suite K
Monmouth
Junction, New Jersey 08852
(Address
of principal executive office) (Zip Code)
(732)
329-8885
Registrant’s
telephone number, including area code:
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2.below):
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13c-4(c))
|
Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year.
On February 17, 2010, we filed with the
Secretary of State for the state of Nevada, a Certificate of Amendment to our
Articles of Incorporation changing our name to “Cytosorbents Corporation” (the
“Name Change”). As more fully disclosed in the Annual Report on Form
10-K for the year ended December 31, 2009, the name change was the result of a
settlement agreement with Alkermes, Inc. A copy of the Certificate of
Amendment is attached hereto as Exhibit 3.01.
Item
8.01 Other Events.
Pursuant
to the name change, effective at the open of business on May 7, 2010, the new
ticker symbol for the Company will be CTSO.
Item
9.01. Financial Statement and Exhibits
(a)
|
Financial
Statements.
|
None
(b)
|
Pro
Forma Financial Information
|
None
(c)
|
Shell
Company Transactions
|
None
(d)
|
Exhibit
Number
|
Description
|
|
3.01
|
Certificate
of Amendment to Articles of Incorporation filed on February 17,
2010
|
|
99.1
|
Press
Release dated May 6, 2010 announcing name
change
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this Report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Medasorb
Technologies Corporation
|
|
|
|
|
|
|
By:
|
/s/
|
|
|
|
Name:
David Lamadrid
|
|
|
|
Title:
Chief Financial Officer
|
|
Dated:
May 7, 2010